Catalyst Pharmaceuticals Inc (CPRX)
16.37
-0.07 (-0.43%)
USD |
NASDAQ |
Mar 28, 16:00
16.36
-0.02 (-0.09%)
After-Hours: 20:00
Catalyst Pharmaceuticals Free Cash Flow: 116.02M for Dec. 31, 2022
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2022 | 116.02M |
| September 30, 2022 | 95.08M |
| June 30, 2022 | 75.41M |
| March 31, 2022 | 64.93M |
| December 31, 2021 | 59.35M |
| September 30, 2021 | 53.32M |
| June 30, 2021 | 43.12M |
| March 31, 2021 | 40.71M |
| December 31, 2020 | 45.02M |
| September 30, 2020 | 44.21M |
| June 30, 2020 | 49.03M |
| March 31, 2020 | 49.83M |
| December 31, 2019 | 34.59M |
| September 30, 2019 | 13.89M |
| June 30, 2019 | -9.346M |
| March 31, 2019 | -28.18M |
| December 31, 2018 | -26.24M |
| September 30, 2018 | -21.86M |
| June 30, 2018 | -17.52M |
| March 31, 2018 | -15.95M |
| December 31, 2017 | -13.74M |
| September 30, 2017 | -14.13M |
| June 30, 2017 | -14.78M |
| March 31, 2017 | -16.01M |
| December 31, 2016 | -18.06M |
| Date | Value |
|---|---|
| September 30, 2016 | -18.27M |
| June 30, 2016 | -20.35M |
| March 31, 2016 | -20.17M |
| December 31, 2015 | -18.04M |
| September 30, 2015 | -17.40M |
| June 30, 2015 | -15.61M |
| March 31, 2015 | -14.36M |
| December 31, 2014 | -13.00M |
| September 30, 2014 | -13.14M |
| June 30, 2014 | -11.25M |
| March 31, 2014 | -10.07M |
| December 31, 2013 | -9.885M |
| September 30, 2013 | -7.394M |
| June 30, 2013 | -6.811M |
| March 31, 2013 | -6.145M |
| December 31, 2012 | -5.193M |
| September 30, 2012 | -4.994M |
| June 30, 2012 | -5.145M |
| March 31, 2012 | -5.464M |
| December 31, 2011 | -4.989M |
| September 30, 2011 | -4.318M |
| June 30, 2011 | -3.882M |
| March 31, 2011 | -3.567M |
| December 31, 2010 | -3.757M |
| September 30, 2010 | -3.817M |
Free Cash Flow Range, Past 5 Years
-28.18M
Minimum
Mar 2019
116.02M
Maximum
Dec 2022
33.27M
Average
43.67M
Median
Free Cash Flow Benchmarks
| ADMA Biologics Inc | -73.42M |
| Ardelyx Inc | -70.04M |
| Rhythm Pharmaceuticals Inc | -177.71M |
| Merrimack Pharmaceuticals Inc | -1.742M |
| Jaguar Health Inc | -34.78M |